Issued Patents All Time
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421222 | Substituted quinazolines as HDAC6 inhibitors | Sylvain Celanire, Joao Fernando DOS SANTOS CARVALHO, Frederik Jan Rita Rombouts, Michele CURCIO, Joana Catarina REIS PEDRO | 2025-09-23 |
| 12358884 | Urolithin derivatives and methods of use thereof | Christopher L. Rinsch, Penelope Andreux, Jonathan Mark Sutton, Eileen Mary Seward, Jamie Knight +4 more | 2025-07-15 |
| 12351567 | Urolithin derivatives and methods of use thereof | Christopher L. Rinsch, Penelope Andreux, Jonathan Mark Sutton, Eileen Mary Seward, Jamie Knight +4 more | 2025-07-08 |
| 12338440 | Intracellular kinase associated with resistance against anti-tumour immune responses, and uses thereof | Antonio Sorrentino, Philipp Beckhove, Tillmann MICHELS, Nisit Khandelwal, Michael Boutros +4 more | 2025-06-24 |
| 12172993 | Heterocyclic kinase inhibitors and uses thereof | Sebastian Meier-Ewert, Nisit Khandelwal, David BANCROFT | 2024-12-24 |
| 12139480 | 5-thiazolecarboxamide kinase inhibitor and uses thereof | Sebastian Meier-Ewert, Nisit Khandelwal | 2024-11-12 |
| 11820751 | Urolithin derivatives and methods of use thereof | Christopher L. Rinsch, Penelope Andreux, Jonathan Mark Sutton, Eileen Mary Seward, Jamie Knight +4 more | 2023-11-21 |
| RE48992 | Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death | Marcus Conrad, Joel Schick, Bettina Proneth | 2022-03-29 |
| 10647687 | Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death | Marcus Conrad, Joel Schick, Bettina Proneth | 2020-05-12 |
| 10280179 | Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death | Marcus Conrad, Joel Schick, Bettina Proneth | 2019-05-07 |
| 9802956 | Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death | Marcus Conrad, Joel Schick, Bettina Proneth | 2017-10-31 |
| 8203001 | Chemical compounds | Ulrich Reiser, Peter Ettmayer, Oliver Kraemer, Walter Spevak | 2012-06-19 |